A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort

[摘要] BackgroundPrevious survival scores for breast cancer patients with cerebral metastases were developed in cohorts receiving heterogeneous treatments, which could have introduced selection biases. A new instrument (WBRT-30-BC) was created from 170 patients receiving whole-brain radiotherapy (WBRT) alone with 30 Gy in 10 fractions.

[学科分类] 肿瘤学

[关键词] breast cancer;cerebral metastases;whole-brain radiotherapy;overall survival time;diagnosis-specific predictive tool